Analyst
Scientist
Equibles does not estimate personal net worth.
Chris Twitty is recorded as Analyst at Scientist. Chris Twitty has spoken on 1 earnings call across 1 company, most recently for Skye Bioscience, Inc. on March 10, 2026. Skye Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Skye Bioscience, Inc. includes Lisa Anson (CEO), Punit Dhillon (CEO, Chief Accounting Officer and Board Member), Paul Grayson (Chairman and Board Member) and 7 others.
“Why 200 milligram weekly was a reasonable starting point for Cbeon and what the translational data now tell us about the exposure required for robust efficacy. Before phase two, we had robust phase one SADMAD safety and PK data.”
Scientist
Analyst
Source not stated
Proxy statement
Start not stated–present
Last confirmed April 16, 2026
Biotechnology · Healthcare
